Supplements and Featured Publications
Focus on Pathways: SERMS in Metastatic Breast Cancer
Research Efforts Underway to Target CEACAM5 in NSCLC
Utilizing Antibody-Drug Conjugates and Other Novel Agents in Lung Cancer
Utilizing Antibody-Drug Conjugates and Other Novel Agents in Lung Cancer comprises articles and videos on experts discussing therapeutic strategies in the pipeline and on the market for their patients with non–small cell lung cancer.
Milestones in Medicine: Updates in BPDCN
Novel Approaches to Targeting TSC1/TSC2 Across Malignancies
Advancing Applications for Antibody-Drug Conjugates in Breast Cancer
Examining Recent Developments in Frontline HCC Treatment
On the Horizon in NSCLC: Antibody Drug Conjugates
Rapid Reviews in Oncology®: September 2022
Novel Therapeutic Approaches to Target FGFR2 Mutations in Cholangiocarcinoma
2022 ESMO Meeting Reporter
Milestones in Medicine: Updates in AML
Milestones in Medicine: Treatment Developments in Biliary Tract Cancers
Dermatologists in Cancer Care®: September 2022
Novel Therapeutic Approaches to Target FGFR Mutations in Solid Tumors
The Current and Future State of Immune Checkpoint Inhibitors in NSCLC
The Emerging Landscape & Novel Biomarkers in Ovarian Cancer
Addressing the Unmet Needs in KRAS G12C–Mutated Solid Tumors
Priority Report: ASCO 2022: Updates in Genetic Testing
ASCO 2022 Meeting Reporter: Updates in Genitourinary Cancers
Milestones in Medicine: Premenopausal Patients With Breast Cancer and Fertility Preservation
Funding provided by TerSera Therapeutics LLC. Content independently developed by OncLive.
Research Efforts Underway for RARA+ MDS and AML
Diagnosis and Trial Options in Sarcoma
Novel Emerging Therapies in Relapsed/Refractory AML
Updates in Acute Graft-Vs-Host Disease
48th Annual Meeting of the EBMT
The 48th Annual Meeting of the EBMT meeting reporter is a publication encompassing the pivotal news presented during the conference, which spans clinical updates in hematologic malignancies.
Trop-2 Directed Antibody-Drug Conjugates for the Treatment of Solid Tumors
Evolving Approaches to ALL Treatment: CAR T-cell Therapy
The Evolving Approaches to ALL Treatment: CAR T-cell Therapy publication covers some of the latest practice-changing advances as it relates to emerging therapeutic strategies for patients with acute lymphoblastic leukemia.
Top 8 Trials From 2021 in Breast Cancer
The Top 2021 Abstracts in Breast Cancer publication provides expert insights on groundbreaking abstracts in breast cancer, with a focus on HER2-positive breast cancer treatment that were presented at medical meetings throughout 2021.
Sponsored in part by Daiichi Sankyo. Content independently developed by OncLive®
2022 Genitourinary Cancers Symposium
The 2022 Genitourinary Cancers Symposium publication includes articles and expert perspectives on the groundbreaking data presented at the 2022 Genitourinary Cancers Symposium in San Francisco, California.